For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide based on the propeptide region of human ADAMTS9. (Peptide available as ab41244.)
Our Abpromise guarantee covers the use of ab28279 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Neutralising||Use at an assay dependent dilution. PubMed: 20551050To neutralize the effects of extracellular ADAMTS9.|
|WB||1/1000 - 1/5000. Predicted molecular weight: 217, 183 , 121 kDa.Can be blocked with ADAMTS9 peptide (ab41244). EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen.|
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"